Boris Klebanov

Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity

Kathryn A. Whitehead, J. Robert Dorkin, Arturo J. Vegas et al. · Nature Communications · 2014 · 603 citations · Full text

Nanoparticles, Nanomedicine, Engineering +7

In Vivo Silencing of the Transcription Factor IRF5 Reprograms the Macrophage Phenotype and Improves Infarct Healing

Gabriel Courties, Timo Heidt, Matthew Sebas et al. · Journal of the American College of Cardiology · 2013 · 277 citations · Full text

Inflammation, Thrombopoiesis, Transcriptional Regulation +11

Cutting Edge: Hypoxia-Inducible Factor 1α and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes

Dmitriy Lukashev, Boris Klebanov, Hidefumi Kojima et al. · The Journal of Immunology · 2006 · 204 citations

Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting Cells

Genc Basha, Tatiana I. Novobrantseva, Nicole L. Rosin et al. · Molecular Therapy · 2011 · 176 citations · Full text

A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

Ramiro Garzon, Michael R. Savona, Rachid Baz et al. · Blood · 2017 · 147 citations · Full text